A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention

Jakub Gumprecht, Magdalena Domek, Gregory Y H Lip

Research output: Contribution to journalJournal articleResearchpeer-review

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention'. Together they form a unique fingerprint.

Medicine & Life Sciences